Feedback
Fibroblast Growth Factor 23 (FGF23), Plasma
2011017
Ordering Recommendation
Mnemonic
FIBRO GF23
Methodology
Quantitative Enzyme Immunoassay
Performed
Varies
Reported
8-11 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Lavender (EDTA). 
Specimen Preparation
Transfer 1.5 mL plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL) 
Storage/Transport Temperature
Frozen. Also acceptable: Refrigerated. 
Unacceptable Conditions
Grossly hemolyzed specimens. 
Remarks
 
Stability
Ambient: Unacceptable; Refrigerated: 2 weeks; Frozen: 3 months 
Reference Interval
By Report
Interpretive Data


Components
Component Test Code*Component Chart NameLOINC
2011018Fibroblast Growth Factor 23, Plasma46699-5
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Autosomal Dominant Hypophosphatemic Rickets
  • Familial Tumoral Calcinosis with Hyperphosphatemia
  • Fibroblast Growth Factor 23 (FGF23)
  • Oncogenic Osteomalacia
  • Phosphatonin
  • X-Linked Hypophosphatemia

Performed at Mayo